
eClinical Solutions Market Size, Share & Trends Analysis Report By Product (eCOA, CTMS, EDC & CDMS), By Delivery Mode (Web-hosted, Licensed Enterprise, Cloud-based), By Development Phase, By End Use, By Region, And Segment Forecasts, 2022 - 2030
Description
eClinical Solutions Market Growth & Trends
The global eClinical solutions market size is expected to reach USD 21.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.6% from 2022 to 2030. Increasing R&D activities by biopharma and pharma companies, application of software solutions in clinical trials, and expanding customer base are anticipated to fuel market growth. During the COVID-19 pandemic, clinical laboratories experienced high demand for COVID-19 tests. eClinical solutions, such as the clinical data management systems assisted these laboratories to seamlessly manage the huge influx of specimens daily. Technological advancements such as electronic data capture and Wi-Fi connectivity are projected to drive the market in the forthcoming years.
As the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development processes are poised to boost market growth over the forecast period. Moreover, digital transformation in the field of clinical trials and preference for data-centric approaches are providing a tremendous push to the market. Demand for integrated clinical IT solutions is increasing due to the massive volume of data generated during clinical development processes. eClinical solutions offer a single source of information that helps optimize the cost by eliminating redundant data entry and by reducing on-site verification and source data verification. Rising awareness regarding these advantages is projected to propel the market.
Increasing adoption of eClinical workflows in trials offers enormous potential in clinical development processes. These solutions can facilitate decision-making in each stage of development. It also helps reduce cost and time between the development phase by utilizing seamless designs and by identifying failing compounds. In addition, it offers rapid access to data and patient safety information, which helps make quick decisions. Market players engage in new product development and strategic alliances including partnership agreements, promotional activities, and acquisitions to keep market rivalry high. For instance, in October 2020, Oracle entered into collaboration with FHI Clinical Inc. for improving clinical trial efficiency and to get therapies to market faster.
eClinical Solutions Market Report Highlights
Oracle
PAREXEL International Corporation
Medidata Solution, Inc.
Bioclinica
DATATRAK International, Inc.
CRF Health
ERT Clinical
eClinicalWorks
IBM Watson Health
OmniComm Systems, Inc. (Anju Software Inc.)
eClinical Solutions
Veeva Systems
Please note The report will be delivered in 2-3 business days upon order notification.
The global eClinical solutions market size is expected to reach USD 21.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.6% from 2022 to 2030. Increasing R&D activities by biopharma and pharma companies, application of software solutions in clinical trials, and expanding customer base are anticipated to fuel market growth. During the COVID-19 pandemic, clinical laboratories experienced high demand for COVID-19 tests. eClinical solutions, such as the clinical data management systems assisted these laboratories to seamlessly manage the huge influx of specimens daily. Technological advancements such as electronic data capture and Wi-Fi connectivity are projected to drive the market in the forthcoming years.
As the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development processes are poised to boost market growth over the forecast period. Moreover, digital transformation in the field of clinical trials and preference for data-centric approaches are providing a tremendous push to the market. Demand for integrated clinical IT solutions is increasing due to the massive volume of data generated during clinical development processes. eClinical solutions offer a single source of information that helps optimize the cost by eliminating redundant data entry and by reducing on-site verification and source data verification. Rising awareness regarding these advantages is projected to propel the market.
Increasing adoption of eClinical workflows in trials offers enormous potential in clinical development processes. These solutions can facilitate decision-making in each stage of development. It also helps reduce cost and time between the development phase by utilizing seamless designs and by identifying failing compounds. In addition, it offers rapid access to data and patient safety information, which helps make quick decisions. Market players engage in new product development and strategic alliances including partnership agreements, promotional activities, and acquisitions to keep market rivalry high. For instance, in October 2020, Oracle entered into collaboration with FHI Clinical Inc. for improving clinical trial efficiency and to get therapies to market faster.
eClinical Solutions Market Report Highlights
- CTMS led the product segment in 2021 and accounted for a revenue share of around 21% owing to benefits of the product such as centralized end-to-end management of clinical trial activities, elimination of reliance on manual processes, real-time status tracking, and maintenance of multiple databases, which cumulatively improve the overall efficiency of clinical trials
- The cloud-based systems segment is anticipated to exhibit an exponential CAGR of 15.1% during the forecast period owing to integrated features such as flexibility, high accessibility, negligible handling costs, and easy data backup. Real-time data is available through these systems, which enables users to take quick decisions and provide high-quality information for risk-based monitoring
- The CROs segment held the largest revenue share in the market in 2021. The segment is projected to rise at a remarkable CAGR of 13.9% during the forecast period owing to the growing inclination of pharmaceutical companies to reduce overall expenditure
- Key companies engage in various business strategies such as mergers and acquisitions and new product development to gain greater market share
Oracle
PAREXEL International Corporation
Medidata Solution, Inc.
Bioclinica
DATATRAK International, Inc.
CRF Health
ERT Clinical
eClinicalWorks
IBM Watson Health
OmniComm Systems, Inc. (Anju Software Inc.)
eClinical Solutions
Veeva Systems
Please note The report will be delivered in 2-3 business days upon order notification.
Table of Contents
190 Pages
- Chapter 1. Research Methodology & Scope
- 1.1 Market Segmentation & Scope
- 1.1.1 Segment Scope
- 1.1.2 Regional Scope
- 1.1.3 Estimates & Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased database
- 1.3.2 GVR’s Internal Database
- 1.3.3 Secondary sources
- 1.3.4 Primary Research
- 1.3.5 Details of Primary Research
- 1.3.5.1 Region specific data for primary interviews
- 1.3.5.1.1 North America
- 1.3.5.1.2 Europe
- 1.3.5.1.3 Asia Pacific
- 1.3.5.1.4 Central & South America
- 1.3.5.1.5 MEA
- 1.4 Information or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis (Model 1)
- 1.6.1.1 Approach 1: Commodity Flow Approach
- 1.6.2 Total Addressable market Analysis (Model 2)
- 1.7 List of Secondary Sources
- 1.8 List of Primary Sources
- 1.9 Abbreviations
- 1.10 Objectives
- 1.10.1 Objective 1
- 1.10.2 Objective 2
- 1.11 Market Definitions
- Chapter 2. Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.3 Competitive Outlook
- Chapter 3. eClinical Solution Market Variables Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent market outlook
- 3.1.2 Ancillary market outlook
- 3.2 Penetration & Growth Prospect Mapping By Delivery Mode, 2021
- 3.3 Pricing Analysis
- 3.3.1 By Product
- 3.3.1.1 eCOA
- 3.3.1.2 EDC & CDMS
- 3.3.1.3 Clinical Analytics Platforms
- 3.3.1.4 Clinical data integration platforms
- 3.3.1.5 Safety solutions
- 3.3.1.6 CTMS
- 3.3.1.7 RTSM
- 3.3.1.8 eTMF
- 3.3.2 BY Delivery mode
- 3.3.3 by Development phase
- 3.4 User Perspective Analysis
- 3.4.1 Market influencer analysis
- 3.5 List of Key End Users
- 3.6 Technology Overview
- 3.6.1 EClinical Solutions changing technology & adoption
- 3.7 Regulatory Framework
- 3.7.1 Regulatory Landscape
- 3.7.1.1 List of regulations, by country
- 3.8 Market Dynamics
- 3.8.1 Market Driver Analysis
- 3.8.1.1 Increasing externalization of clinical trial studies by large pharmaceutical and biopharmaceutical companies
- 3.8.1.2 Advantages of eClinical solutions
- 3.8.1.3 Presence of strong range of products in pipeline
- 3.8.2 Market Restraints Analysis
- 3.8.2.1 Scarcity of skilled research professionals
- 3.8.2.2 Lack of recognition
- 3.8.3 Industry challenges
- 3.9 Industry Analysis - Porter’s
- 3.10 eClinical Solutions - SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
- Chapter 4. COVID-19 Impact Analysis
- 4.1 COVID-19 Outbreak
- 4.2 Impact on Ongoing Clinical Trials
- 4.2.1 Obstacles in clinical trials:
- 4.2.2 Disrupted clinical trials
- 4.3 Demand Analysis
- 4.3.1 Product Pipeline Analysis, by Stage for COVID-19
- 4.4 Virtual Clinical Trials
- 4.5 Recent Developments & Strategic Outcomes
- 4.5.1 Strategies implemented by companies
- 4.5.1.1 Oracle
- 4.5.1.2 PARAXEL International Corporation
- 4.5.1.3 Bioclinica
- 4.5.1.4 Datatrak International, Inc.
- 4.5.1.5 Medidata Solution, Inc.
- 4.5.1.6 ERT Clinical
- 4.5.1.7 eClinicalWorks
- 4.5.1.8 IBM Watson Health
- 4.5.1.9 eClinical Solutions
- 4.5.1.10 Veeva Systems
- 4.5.1.11 Elsevier
- 4.5.1.12 IQVIA
- 4.5.1.13 Pharmaceutical Product Development (PPD)
- 4.5.1.14 ICON, plc
- 4.5.1.15 PRA Health Sciences
- 4.5.1.16 Covance Inc
- Chapter 5. eClinical Solutions Market: Competitive Analysis
- 5.1 Market Participation Categorization
- 5.2 Public Companies
- 5.2.1 Company market position analysis
- 5.3 Company Market Share Analysis
- 5.3.1 eClinical solutions estimated company market share analysis, 2021
- 5.4 Competitive & Vendor Landscape
- 5.4.1 List of key strategies, by company
- 5.4.2 Market leader
- 5.4.3 Innovators
- 5.4.4 Vendor Landscape
- 5.4.4.1 List of eClinical service providers
- Chapter 6. eClinical Solutions Market: Product Analysis
- 6.1 Product Business Analysis
- 6.1.1 Electronic clinical outcome assessment (ECOA)
- 6.1.1.1 ECOA market estimates and forecasts, 2017 - 2030 (USD Million)
- 6.1.2 Electronic data capture (EDC) & clinical data management systems (CDMS)
- 6.1.2.1 EDC & CDMS market estimates and forecasts, 2017 - 2030 (USD Million)
- 6.1.3 Clinical analytics platform
- 6.1.3.1 clinical analytics platform market estimates and forecasts, 2017 - 2030 (USD Million)
- 6.1.4 Clinical data integration platform
- 6.1.4.1 Clinical data integration platform market estimates and forecasts, 2017 - 2030 (USD Million)
- 6.1.5 Safety solutions
- 6.1.5.1 Safety solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 6.1.6 Clinical trial management systems (CTMS)
- 6.1.6.1 CTMS market estimates and forecasts, 2017 - 2030 (USD Million)
- 6.1.7 Randomization and trial supply management (RTSM)
- 6.1.7.1 RTSM market estimates and forecasts, 2017 - 2030 (USD Million)
- 6.1.8 Electronic trial master file (eTMF)
- 6.1.8.1 eTMF market estimates and forecasts, 2017 - 2030 (USD Million)
- Chapter 7. eClinical Solutions Market : Delivery Mode Analysis
- 7.1 Delivery Mode Business Analysis
- 7.1.1 Web-hosted
- 7.1.2 Web-hosted market estimates and forecasts, 2017 - 2030 (USD Million)
- 7.1.3 Licensed Enterprise
- 7.1.4 Licensed enterprise market estimates and forecasts, 2017 - 2030 (USD Million)
- 7.1.5 Cloud-based
- 7.1.5.1 Cloud based market estimates and forecasts, 2017 - 2030 (USD Million)
- Chapter 8. eClinical Solutions Market : Development Phase Analysis
- 8.1 Development Phase Business Analysis
- 8.2 Phase I
- 8.2.1 Phase I market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.2.2 Phase II
- 8.2.2.1 Phase II market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.3 Phase III
- 8.3.1 Phase III market estimates and forecasts, 2017 - 2030 (USD Million)
- 8.3.2 Phase IV
- 8.3.2.1 Phase IV market estimates and forecasts, 2017 - 2030 (USD Million)
- Chapter 9. eClinical Solutions Market: End-use Analysis
- 9.1 End-use Business Analysis
- 9.2 Hospitals/Healthcare Providers
- 9.2.1 Hospitals market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.2.2 Contract Research Organizations (CROs)
- 9.2.2.1 CROs market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.3. Academic institutes
- 9.3.1 Academic institutes market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.4 Pharma & biotech organizations
- 9.4.1 Pharma & biotech organizations market estimates and forecasts, 2017 - 2030 (USD Million)
- 9.5 Medical device manufacturers
- 9.5.1 Medical device manufacturers market estimates and forecasts, 2017 - 2030 (USD Million)
- Chapter 10. eClinical Solutions Market: Regional Market Analysis, By Product, 2017 - 2030 (USD Million)
- 10.1 Definition & Scope
- 10.2 Regional Market Share Analysis, 2021& 2030
- 10.3 Regional Market Dashboard
- 10.4 Regional Market Snapshot
- 10.5 Regional Market Share and Leading Players, 2021
- 10.5.1 North America
- 10.5.2 Europe
- 10.5.3 Asia Pacific
- 10.5.4 Central & South America
- 10.5.5 MEA
- 10.6 Market Size, & Forecasts, and Trend Analysis, 2017 to 2030
- 10.6.1 North America
- 10.6.2 North America eClinical solutions market estimates and forecasts by countries, 2017 - 2030 (USD Million)
- 10.6.3 U.S.
- 10.6.3.1 U.S. eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.4 Canada
- 10.6.4.1 Canada eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.5 Mexico
- 10.6.5.1 Mexico eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.6 Europe
- 10.6.7 Europe eClinical solutions market estimates and forecasts by countries, 2017 - 2030 (USD Million)
- 10.6.8 U.K.
- 10.6.8.1 U.K. eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.9 Germany
- 10.6.9.1 Germany eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.10 France
- 10.6.10.1 France eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.11 Italy
- 10.6.11.1 Italy eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.12 Spain
- 10.6.12.1 Spain eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.13 Netherlands
- 10.6.13.1 Netherlands eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.14 Sweden
- 10.6.14.1 Sweden eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.15 Denmark
- 10.6.15.1 Denmark eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.16 Asia Pacific
- 10.6.17 Asia Pacific eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.18 Japan
- 10.6.18.1 Japan eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.19 China
- 10.6.19.1 China eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.20 India
- 10.6.20.1 India eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.21 South Korea
- 10.6.21.1 South Korea eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.22 Australia
- 10.6.22.1 Australia eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.23 New Zealand
- 10.6.23.1 New Zealand eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.24 Taiwan
- 10.6.24.1 Taiwan eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.25 Hong Kong
- 10.6.25.1 Hong Kong eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.26 Singapore
- 10.6.26.1 Singapore eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.27 Thailand
- 10.6.27.1 Thailand eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.28 Vietnam
- 10.6.28.1 Vietnam eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.29 Central & South America
- 10.6.30 Central & South America eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.31 Brazil
- 10.6.31.1 Brazil eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.32 Argentina
- 10.6.32.1 Argentina eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.33 Chile
- 10.6.33.1 Chile eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.34 MEA
- 10.6.35 MEA eClinical solutions market estimates and forecasts by countries, 2017- 2030 (USD MILLION)
- 10.6.36 South Africa
- 10.6.36.1 South Africa eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.37 Saudi Arabia
- 10.6.37.1 Saudi Arabia eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.38 United Arab Emirates
- 10.6.38.1 U.A.E. eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.39 Egypt
- 10.6.39.1 Egypt eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- 10.6.40 Qatar
- 10.6.40.1 Qatar eClinical solutions market estimates and forecasts, 2017 - 2030 (USD Million)
- Chapter 11. Company Profiles
- 11.1 Oracle
- 11.1.1 Company Overview
- 11.1.2 Financial Performance
- 11.1.3 Product Benchmarking
- 11.1.4 Strategic Initiatives
- 11.2 PAREXEL International Corporation
- 11.2.1 Company Overview
- 11.2.2 Financial Performance
- 11.2.3 Product Benchmarking
- 11.2.4 Strategic Initiatives
- 11.3 Medidata Solution, Inc.
- 11.3.1 Company Overview
- 11.3.2 Financial Performance
- 11.3.3 Product Benchmarking
- 11.3.4 Strategic Initiatives
- 11.4 Bioclinica
- 11.4.1 Company Overview
- 11.4.2 Product Benchmarking
- 11.4.3 Strategic Initiatives
- 11.5 DATATRAK International, Inc.
- 11.5.1 Company Overview
- 11.5.2 Financial Performance
- 11.5.3 Product Benchmarking
- 11.5.4 Strategic Initiatives
- 11.6 CRF Health
- 11.6.1 Company Overview
- 11.6.2 Product Benchmarking
- 11.6.3 Strategic Initiatives
- 11.7 ERT Clinical
- 11.7.1 Company Overview
- 11.7.2 Product Benchmarking
- 11.7.3 Strategic Initiatives
- 11.8 eClinicalWorks
- 11.8.1 Company Overview
- 11.8.2 Product Benchmarking
- 11.8.3 Strategic Initiatives
- 11.9 IBM Watson Health
- 11.9.1 Company Overview
- 11.9.2 Product Benchmarking
- 11.9.3 Strategic Initiatives
- 11.10 OmniComm Systems, Inc. (Anju Software Inc.)
- 11.10.1 Company Overview
- 11.10.2 Financial Performance
- 11.10.3 Product Benchmarking
- 11.10.4 Strategic Initiatives
- 11.11 eClinical Solutions
- 11.11.1 Company Overview
- 11.11.2 Financial Performance
- 11.11.3 Product Benchmarking
- 11.11.4 Strategic Initiatives
- 11.12 Veeva Systems
- 11.12.1 Company Overview
- 11.12.2 Financial Performance
- 11.12.3 Product Benchmarking
- 11.12.4 Strategic Initiatives
- Chapter 12. Recommendations/Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.